RCT Glargine vs NPH for Treatment of DM in Pregnancy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT06619301
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT06619301
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06619301. Randomized; no masking; primary purpose treatment. Start 2024-04-01 (actual); primary completion 2026-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RCT Glargine vs NPH for Treatment of DM in Pregnancy
- Condition
- Diabetes Mellitus in Pregnancy
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Condition
- Gestational Diabetes Mellitus, Class A2
- Intervention (Drug)
- Insulin glargine
- Intervention (Drug)
- insulin NPH
- Lead sponsor
- Loyola University
Record details
- Record id
cardio:ct-nct06619301- Content hash
9bf5b69f3ab843c0cec8cfd86f22a047bebcff6f1722841932d26b3a5cfbda1e